Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Aripiprazole on Patients With "Metabolic Syndrome": An Open-Label Trial

NCT00224822 is registered in ClinicalTrials.gov with New Mexico VA Healthcare System as lead sponsor.

NCT NCT00224822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00224822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Aripiprazole on Patients With "Metabolic Syndrome": An Open-Label Trial
Lead sponsor
New Mexico VA Healthcare System
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2004
Completion date
March 31, 2007
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, metabolic syndrome x, schizoaffective disorder, schizophrenia